PLK1 and hepatocellular carcinoma: One of the target genes of mir-100 is Polo-Like Kinase 1 (PLK1), a proto-oncogene that encodes a serine/threonine-protein kinase that plays a crucial role in cell cycle regulation and is a potential therapeutic target for HCC [19,20].